Cognitive impairment in neurofibromatosis type 1

被引:0
|
作者
Ozonoff, S
机构
[1] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1999年 / 89卷 / 01期
关键词
NF1; neuropsychology; cognitive function; learning disabilities;
D O I
10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Neurofibromatosis type 1 (NF1) is associated with a broad range of relatively nonspecific cognitive impairments, including low IQ, learning disabilities, and behavioral difficulties. While early studies indicated that the cognitive phenotype of NF1 resembles that of nonverbal learning disabilities (NLD), later research has found that the impairments are broader and do not fit the NLD profile well. Language-based deficits and executive dysfunction have also been found in empirical studies. There is some evidence that neuropsychological impairment may be correlated with the underlying central nervous system involvement of NF1, but this theory has not been consistently supported across studies. Further work clarifying the cognitive phenotype of NF1 is needed, especially investigations that employ appropriate comparison groups matched for intellectual level. Am. J. Med. Genet. (Semin. Med. Genet.) 89:45-52. 1999. (C) 1999 Wiley Liss, Inc.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [21] MAPK Levels as a Biomarker of Cognitive Deficits in Neurofibromatosis Type 1
    Rosser, T.
    Lee, Y. S.
    Enrique, N.
    Silva, A.
    Bearden, C.
    ANNALS OF NEUROLOGY, 2012, 72 : S216 - S216
  • [22] Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings
    Erdogan-Bakar, Emel
    Cinbis, Mine
    Ozyurek, Hamit
    Kiris, Nurcihan
    Altunbasak, Sakir
    Anlar, Banu
    TURKISH JOURNAL OF PEDIATRICS, 2009, 51 (06) : 565 - 571
  • [23] The nature and frequency of cognitive deficits in children with neurofibromatosis type 1
    Hyman, SL
    Shores, A
    North, KN
    NEUROLOGY, 2005, 65 (07) : 1037 - 1044
  • [24] Predictors of cognitive impairment in type 1 diabetes
    Brismar, Tom
    Maurex, Liselotte
    Cooray, Gerald
    Juntti-Berggren, Lisa
    Lindstrom, Per
    Ekberg, Karin
    Adner, Nils
    Andersson, Sten
    PSYCHONEUROENDOCRINOLOGY, 2007, 32 (8-10) : 1041 - 1051
  • [25] Selective impairment of the executive attentional network in adult patients with neurofibromatosis type 1
    Wang, Xingchao
    Wu, Qiong
    Tang, Hanlu
    Zhao, Fu
    Yang, Zhijun
    Wang, Bo
    Li, Peng
    Wang, Zhenmin
    Wu, Yanhong
    Fan, Jin
    Liu, Pinan
    NEUROREPORT, 2019, 30 (14) : 921 - 926
  • [26] BEHAVIORAL AND COGNITIVE OUTCOMES FOR CLINICAL TRIALS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1
    Walsh, Karin S.
    Janusz, Jennifer
    Wolters, Pamela L.
    NEUROLOGY, 2016, 86 (19) : 1849 - 1849
  • [27] Cognitive Profiles of Neurofibromatosis Type 1 Patients With Minor Brain Malformations
    Acosta, Maria T.
    Walsh, Karin S.
    Kardel, Peter G.
    Kutteruf, Rachel E.
    Bhatt, Rujuta R.
    Bouton, Tara C.
    Vezina, Louis-Gilbert
    Packer, Roger J.
    PEDIATRIC NEUROLOGY, 2012, 46 (04) : 231 - 234
  • [28] The Cognitive Profile of Preschool-Aged Children with Neurofibromatosis Type 1
    Sangster, Jennifer
    Shores, E. Arthur
    Watt, Sharon
    North, Kathryn N.
    CHILD NEUROPSYCHOLOGY, 2011, 17 (01) : 1 - 16
  • [29] Effect of neuroradiological findings on cognitive functions in patients with neurofibromatosis type 1
    Mert, Gillen Gul
    Ucar, Habibe Koc
    CUKUROVA MEDICAL JOURNAL, 2019, 44 (04): : 1208 - 1214
  • [30] Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1
    Gorana Pobric
    Jason R. Taylor
    Hemavathy M. Ramalingam
    Emily Pye
    Louise Robinson
    Grace Vassallo
    JeYoung Jung
    Misty Bhandary
    Karolina Szumanska-Ryt
    Louise Theodosiou
    D. Gareth Evans
    Judith Eelloo
    Emma Burkitt-Wright
    Johan Hulleman
    Jonathan Green
    Shruti Garg
    Journal of Autism and Developmental Disorders, 2022, 52 : 1478 - 1494